About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.
The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).
Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR.
The main lines of research are:
IP: Olga Simó Servat Collaborators: Ana Boixadera Espax, Marina Giralt Arnaiz, Cristina Udina Argilaga Funding agency: Instituto de Salud Carlos III Funding: 82280 Reference: PI20/01703 Duration: 01/01/2021 - 30/06/2025
IP: Yolima Cossio Gil Collaborators: Cristina Hernández Pascual, Natalia Borruel Sainz, Xavier Serra Ruiz, Gemma Galán Martinez, Monica Sanchez Bartres, Marta Ferri Peradalta Funding agency: The Innovative Medicines Initiative Funding: 1097257.5 Reference: H2O_IMI2-2020 Duration: 01/10/2020 - 30/09/2025
IP: Rafael Simó Canonge Collaborators: Marc Rivas Agudo, Cristina Hernández Pascual, José García Arumí Funding agency: Instituto de Salud Carlos III Funding: 573650 Reference: ICI20/00129 Duration: 01/01/2021 - 31/10/2026
IP: Maria Jose Soler Romeo Collaborators: Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá, Juan Carlos León Román, Irene Martinez Diaz Funding agency: Instituto de Salud Carlos III Funding: 122210 Reference: PI21/01292 Duration: 01/01/2022 - 30/06/2026
PMID: 37944280 Journal: Journal of Stroke & Cerebrovascular Diseases Year: 2023 Reference: J Stroke Cerebrovasc Dis. 2023 Nov 7;33(1):107467. doi: 10.1016/j.jstrokecerebrovasdis.2023.107467. Impact factor: Publication type: Paper in international publication Authors: Agudelo, Victor Hugo; Alonso, Javier Robles; Alvarez, Maria Eugenia Vazquez; Amat-Santos, Ignacio J; Andraka, Leire; Anton, Salvador Alvarez; Aquino, Rosa Sanchez; Arellano, Manuel Vizcaino; Arroyo, Jose Ramon Ruiz; Arzamendi, Dabit et al. DOI: 10.1016/j.jstrokecerebrovasdis.2023.107467
PMID: 37951468 Journal: Cirugia espanola Year: 2023 Reference: Cir Esp (Engl Ed). 2023 Nov 9:S2173-5077(23)00193-X. doi: 10.1016/j.cireng.2023.01.009. Impact factor: Publication type: Paper in international publication Authors: Bustamante, Alejandro; Delgado, Pilar; Escudero-Martinez, Irene; Garcia-Rodriguez, Paula; Guaman-Pilco, Daisy R; Jimenez-Balado, Joan; Lamana-Vallverdu, Marcel; Lopez Cano, Manuel; Montaner, Joan; Pala, Elena et al. DOI: 10.1016/j.cireng.2023.01.009
PMID: 37963304 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2023 Reference: J Clin Oncol. 2023 Nov 14:JCO2300339. doi: 10.1200/JCO.23.00339. Impact factor: Publication type: Paper in international publication Authors: Agarwal, Neeraj; Augustin, Salvador; Barnicle, Alan; Chi, Kim N; Ciudin, Andreea; de Bono, Johann S; Ferrer-Costa, Roser; Fizazi, Karim; Gabriel-Medina, Pablo; Hussain, Maha et al. DOI: 10.1200/JCO.23.00339
PMID: 37981529 Journal: European Journal of Internal Medicine Year: 2023 Reference: Eur J Intern Med. 2023 Nov 17:S0953-6205(23)00406-5. doi: 10.1016/j.ejim.2023.11.009. Impact factor: Publication type: Paper in international publication Authors: Araujo-Castro, Marta; Atkova, Irina; Bernabeu, Ignacio; Biagetti, Betina; Chew, Han Shi Jocelyn; Dios, Elena; Frondelius, Tuomas; Jansson, Miia; Miettunen, Jouko; Rello, Jordi et al. DOI: 10.1016/j.ejim.2023.11.009
PMID: 33708550 Journal: Gland Surgery Year: 2021 Reference: Gland Surg. 2021 Feb;10(2):678-689. doi: 10.21037/gs-20-712. Impact factor: 2.953 Publication type: Paper in international publication Authors: Diez, Juan J, Alcazar, Victoria, Iglesias, Pedro, Romero-Lluch, Ana, Sastre, Julia, Corral, Begona Perez, Zafon, Carles, Galofre, Juan Carlos, Pamplona, Maria Jose et al. DOI: 10.21037/gs-20-712
PMID: 33686759 Journal: MOLECULAR NUTRITION & FOOD RESEARCH Year: 2021 Reference: Mol Nutr Food Res. 2021 May;65(9):e2000672. doi: 10.1002/mnfr.202000672. Epub 2021 Mar 19. Impact factor: 5.82 Publication type: Paper in international publication Authors: Herrero, Laura, Cervela, Luis, Ribeiro, Marcelo L, Simo, Rafael, Villena, Josep A, Velilla, Marc, Pardo, Rosario et al. DOI: 10.1002/mnfr.202000672
PMID: 33484411 Journal: ENDOCRINE Year: 2021 Reference: Endocrine. 2021 Jul;73(1):131-140. doi: 10.1007/s12020-021-02610-7. Epub 2021 Jan 23. Impact factor: 3.633 Publication type: Paper in international publication Authors: Anda, Emma, Povoa, Antonia, Quiceno, Hernan, Sanchez-Gomez, Nancy M, Gonzalez, Clarisa, Garcia-Pascual, Luis, Gomez de la Riva, Ines, Blanco, Concha, Meizoso, Telma, Riesco-Eizaguirre, Garcilaso et al. DOI: 10.1007/s12020-021-02610-7
PMID: 33401779 Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Year: 2021 Reference: Int J Mol Sci. 2021 Jan 2;22(1). pii: ijms22010415. doi: 10.3390/ijms22010415. Impact factor: 5.924 Publication type: Review in international publication Authors: Biagetti, Betina, Simo, Rafael et al. DOI: 10.3390/ijms22010415
PMID: 27460652 Journal: Revista de calidad asistencial : organo de la Soci Year: 2017 Reference: Rev Calid Asist. 2017 Mar - Apr;32(2):112. doi: 10.1016/j.cali.2016.06.007. Epub 2016 Jul 22. Impact factor: 0 Publication type: Letter or abstract Authors: Biagetti, B, Aulinas, A, Dalama, B, Nogues, R, Zafon, C, Mesa, J et al. DOI: 10.1016/j.cali.2016.06.007
The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.
This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.
